Real-time assay for the detection of botulinum toxin
A real-time portable and rapid detection assay to identify the presence of biologically active toxins such as botulinum toxins. The proteolytic activity of BoNT/A is measured using a peptide cleavage assay, where a fluorescent substrate is cleaved by BoNT/A, resulting in increased fluorescence. This fluorescence can be monitored in real-time using a fluorescence detection instrument, such as a real-time PCR system that has been modified to implement a detection algorithm specific to the identification of the target toxin.
1. A device for detecting the presence of biologically active botulinum toxin, comprising:
a chamber for receiving a test sample, said chamber including a peptide substrate comprising SEQ. ID NO. 1 that is labeled with a fluorophore and a quencher and has a cleavage site responsive to biologically active botulinum toxin positioned between said fluorophore and said quencher;
a detector for measuring the amount of fluorescence emitted from said sample and outputting a corresponding fluorescence reading positioned proximately to said chamber;
a microcontroller interconnected to said detector that is programmed to acquire said fluorescence reading and to determine whether any biologically active botulinum toxin is present in said sample based on said fluorescence reading.
2. The device of claim 1 , wherein said chamber comprises a real-time PCR detector and said microcontroller is associated with said PCR detector and has been additionally programmed to acquire said fluorescence reading after a plurality of cycles and to determine whether any biologically active botulinum toxin is present in said sample based on the change in said fluorescence reading over a plurality of said cycles.
3. The device of claim 1 , further comprising a negative control sample positioned in said chamber that has fluorescence that is separately detectable by said detector.
4. A device for detecting the presence of biologically active botulinum toxin, comprising:
a chamber for receiving a test sample, said chamber including a peptide substrate labeled with a fluorophore and a quencher and having a cleavage site responsive to biologically active botulinum toxin positioned between said fluorophore and said quencher;
a detector for measuring the amount of fluorescence emitted from said sample and outputting a corresponding fluorescence reading positioned proximately to said chamber;
a microcontroller interconnected to said detector that is programmed to acquire said fluorescence reading and to determine whether any biologically active botulinum toxin is present in said sample based on said fluorescence reading; and
a negative control sample positioned in said chamber that has fluorescence that is separately detectable by said detector, wherein said negative control sample is a peptide selected from the group consisting of SEQ. ID NO. 2, SEQ. ID NO. 3, SEQ. ID NO. 4, and SEQ. ID NO. 5.
5. The device of claim 3 , wherein said microcontroller is programmed to determine whether biologically active botulinum toxin in present in said sample based on the change in magnitude of said fluorescence reading of said test sample over a plurality of said cycles relative to the change in magnitude of said fluorescence reading of said negative control sample over said plurality of said cycles.
6. The device of claim 5 , wherein said microcontroller is further programmed to determine whether biologically active botulinum toxin in present in said sample based on an average change in slope of said fluorescence of said negative control sample over said plurality of said cycles and an average change in slope of said fluorescence of said test sample over said plurality of said cycles.
7. The device of claim 4 , wherein said negative control sample is a peptide selected from the group consisting of SEQ. ID NO. 2, SEQ. ID NO. 3, SEQ. ID NO. 4, and SEQ. ID NO. 5.